Screener
Icahn Enterprises IEP Pharma — Inventory Net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Icahn Enterprises in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Icahn Enterprises’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-090605
| Line item | Investment | Energy | Automotive | Food Packaging | Real Estate | Home Fashion | Pharma | Holding Company | Consolidated |
|---|---|---|---|---|---|---|---|---|---|
| Investments | 1,388 | 12 | — | — | 98 | — | — | — | 1,498 |
| Accounts receivable, net | — | 327 | 29 | 67 | 13 | 27 | 25 | — | 488 |
| Related party note receivable | — | — | — | — | 136 | — | — | — | 136 |
| Inventories, net | — | 603 | 161 | 105 | — | 86 | 23 | — | 978 |
| Property, plant and equipment, net | — | 2,282 | 366 | 148 | 765 | 52 | — | 3 | 3,616 |
| Goodwill and intangible assets, net | — | 130 | 312 | 20 | — | 20 | 137 | — | 619 |
| Other assets | 1,132 | 378 | 388 | 80 | 109 | 22 | 9 | 245 | 2,363 |
| Total assets | $4,323 | $4,469 | $1,290 | $428 | $1,157 | $211 | $216 | $796 | $12,890 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Icahn Enterprises's pharma — inventory net?
- Icahn Enterprises (IEP) reported pharma — inventory net of $23M in Q2 2026.
- How has Icahn Enterprises's pharma — inventory net changed year-over-year?
- Icahn Enterprises's pharma — inventory net increased by 4.5% year-over-year, from $22M to $23M.
- What is the long-term trend for Icahn Enterprises's pharma — inventory net?
- Over 4 years (2021 to 2025), Icahn Enterprises's pharma — inventory net has grown at a 17.7% compound annual growth rate (CAGR), from $50M to $96M.
- What does pharma — inventory net mean?
- Represents the total value of raw materials, work-in-progress, and finished pharmaceutical products held by the segment. This metric is vital for assessing supply chain efficiency and the segment's ability to meet market demand without overstocking. Effective inventory management is crucial for maintaining margins and avoiding obsolescence in the pharmaceutical sector.
Ask your AI about Icahn Enterprises's pharma — inventory net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude